Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,036 | 237 | 88.1% |
| Education | $683.08 | 37 | 11.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $834.86 | 33 | $0 (2024) |
| COLOPLAST CORP | $570.69 | 57 | $0 (2024) |
| Janssen Biotech, Inc. | $382.30 | 14 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $302.64 | 15 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $302.41 | 8 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $241.99 | 12 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $228.61 | 9 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $223.91 | 12 | $0 (2022) |
| Myovant Sciences Inc. | $223.26 | 9 | $0 (2022) |
| UroGen Pharma, Inc. | $157.08 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $802.73 | 31 | Janssen Biotech, Inc. ($179.41) |
| 2023 | $609.11 | 20 | Myriad Genetic Laboratories, Inc. ($100.32) |
| 2022 | $752.72 | 32 | Myriad Genetic Laboratories, Inc. ($157.59) |
| 2021 | $1,366 | 67 | Astellas Pharma US Inc ($389.70) |
| 2020 | $662.86 | 44 | Coloplast Corp ($196.03) |
| 2019 | $788.11 | 46 | Astellas Pharma US Inc ($130.12) |
| 2018 | $432.72 | 20 | Astellas Pharma US Inc ($120.19) |
| 2017 | $303.88 | 14 | Janssen Biotech, Inc. ($61.23) |
All Payment Transactions
274 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/04/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Oncology | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: UROLOGY | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: UROLOGY | ||||||
| 10/17/2024 | 180 Medical, Inc. | GENTLECATH GLIDE (Device) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: CONTINENCE CARE | ||||||
| 09/27/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/24/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Immunotherapy | ||||||
| 09/18/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Urology Gynecology | ||||||
| 08/14/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $52.98 | General |
| Category: Urology | ||||||
| 07/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: Oncology | ||||||
| 07/15/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Immunotherapy | ||||||
| 06/13/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Continence Care | ||||||
| 06/11/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Oncology | ||||||
| 05/30/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $44.78 | General |
| Category: UROLOGY | ||||||
| 05/29/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $19.90 | General |
| 05/28/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $68.00 | General |
| Category: Oncology | ||||||
| 05/02/2024 | Endo USA, Inc. | AVEED (Biological) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: UROLOGY | ||||||
| 04/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Oncology | ||||||
| 04/10/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/28/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: rezum_URO | ||||||
| 03/25/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $22.13 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,093 | 1,761 | $252,591 | $97,429 |
| 2022 | 10 | 1,226 | 2,026 | $254,654 | $100,269 |
| 2021 | 10 | 1,255 | 1,963 | $248,849 | $97,156 |
| 2020 | 11 | 1,614 | 2,445 | $266,532 | $101,589 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 341 | 566 | $93,390 | $39,318 | 42.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 16 | 126 | $53,550 | $16,812 | 31.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 52 | 57 | $27,075 | $11,987 | 44.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $29,750 | $10,839 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 97 | $22,795 | $9,535 | 41.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 81 | $7,148 | $3,910 | 54.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 298 | 450 | $13,500 | $3,867 | 28.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 193 | 278 | $3,892 | $611.60 | 15.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 21 | $1,491 | $549.36 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 347 | 556 | $91,740 | $39,434 | 43.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 14 | 114 | $48,450 | $16,288 | 33.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 62 | 68 | $32,300 | $14,046 | 43.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 108 | $25,380 | $10,747 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 77 | 77 | $26,950 | $9,897 | 36.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 21 | 84 | $7,413 | $4,400 | 59.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 267 | 412 | $12,360 | $3,509 | 28.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 333 | 576 | $8,064 | $1,279 | 15.9% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 14 | 19 | $1,349 | $420.71 | 31.2% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 12 | 12 | $648.00 | $248.10 | 38.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 372 | 589 | $93,445 | $39,644 | 42.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 14 | 108 | $45,900 | $16,921 | 36.9% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 60 | 66 | $31,002 | $13,232 | 42.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 92 | 92 | $32,272 | $11,200 | 34.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 80 | $18,240 | $8,529 | 46.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 251 | 349 | $10,787 | $2,838 | 26.3% |
About Dr. Cameron Wilson, MD
Dr. Cameron Wilson, MD is a Urology healthcare provider based in La Mesa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770780157.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cameron Wilson, MD has received a total of $5,719 in payments from pharmaceutical and medical device companies, with $802.73 received in 2024. These payments were reported across 274 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($5,036).
As a Medicare-enrolled provider, Wilson has provided services to 5,188 Medicare beneficiaries, totaling 8,195 services with total Medicare billing of $396,442. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location La Mesa, CA
- Active Since 06/29/2007
- Last Updated 05/05/2015
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1770780157
Products in Payments
- XTANDI (Drug) $498.38
- ERLEADA (Drug) $298.67
- PROVENGE (Drug) $263.21
- SpeediCath (Device) $252.84
- ELIGARD (Drug) $223.91
- ORGOVYX (Drug) $223.26
- Nubeqa (Drug) $204.27
- AVEED (Biological) $175.49
- SPEEDICATH (Device) $164.76
- Prolaris (Device) $157.59
- JELMYTO (Drug) $157.08
- CONTINENCE CARE (Device) $153.09
- XIAFLEX (Biological) $131.62
- GEMTESA (Drug) $126.04
- PYLARIFY (Drug) $98.86
- Axumin (Drug) $94.62
- CAMCEVI (Drug) $94.47
- AQUABEAM ROBOTIC SYSTEM (Device) $89.60
- NEOX (Medical Supply) $84.33
- LoFric (Device) $72.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in La Mesa
Paul Dato, M.d, M.D
Urology — Payments: $474,739
Franklin Gaylis, M.d, M.D
Urology — Payments: $122,120
Dr. Mohamed Bidair, M.d, M.D
Urology — Payments: $51,367
Dr. Eileen Byrne, M.d, M.D
Urology — Payments: $14,356
Scott Brown, M.d, M.D
Urology — Payments: $11,309
Wilfred Kearse, M.d, M.D
Urology — Payments: $4,241